Dr. Lal PathLabs Limited (LALPATHLAB.NS)
INR 3018.6
(-0.67%)
INR 3018.6
(-0.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 8.65 Billion INR | 36.91% |
| 2022 | 3.4 Billion INR | -25.19% |
| 2021 | 4.54 Billion INR | 26.39% |
| 2020 | 3.59 Billion INR | 32.8% |
| 2019 | 2.7 Billion INR | 5.93% |
| 2018 | 2.55 Billion INR | -29.48% |
| 2017 | 3.62 Billion INR | 73.15% |
| 2016 | 2.09 Billion INR | 14.9% |
| 2015 | 1.82 Billion INR | 41.54% |
| 2014 | 1.28 Billion INR | 13.22% |
| 2013 | 1.13 Billion INR | 45.02% |
| 2012 | 784.39 Million INR | 15.46% |
| 2011 | 679.39 Million INR | 53.65% |
| 2010 | 442.17 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.67 Billion INR | 23.58% |
| 2024 Q1 | 1.35 Billion INR | 25.16% |
| 2023 Q1 | 1.11 Billion INR | 20.5% |
| 2023 FY | 4.65 Billion INR | 36.91% |
| 2023 Q3 | 1.22 Billion INR | -23.19% |
| 2023 Q4 | 1.08 Billion INR | -12.04% |
| 2023 Q2 | 1.6 Billion INR | 44.01% |
| 2022 Q3 | 856 Million INR | -24.71% |
| 2022 Q1 | 816 Million INR | -4.57% |
| 2022 FY | 3.4 Billion INR | -25.19% |
| 2022 Q4 | 922 Million INR | 7.71% |
| 2022 Q2 | 1.13 Billion INR | 39.34% |
| 2021 Q2 | 1.21 Billion INR | -53.8% |
| 2021 FY | 4.54 Billion INR | 26.39% |
| 2021 Q3 | 785 Million INR | -35.12% |
| 2021 Q1 | 2.61 Billion INR | 62.57% |
| 2021 Q4 | 855.08 Million INR | 8.93% |
| 2020 Q2 | 1.63 Billion INR | 291.87% |
| 2020 Q4 | 1.61 Billion INR | -10.35% |
| 2020 FY | 3.59 Billion INR | 32.8% |
| 2020 Q1 | 418 Million INR | -49.43% |
| 2020 Q3 | 1.79 Billion INR | 9.71% |
| 2019 FY | 2.7 Billion INR | 5.93% |
| 2019 Q4 | 826.54 Million INR | -21.73% |
| 2019 Q3 | 1.05 Billion INR | -24.14% |
| 2019 Q2 | 1.39 Billion INR | 13.73% |
| 2019 Q1 | 1.22 Billion INR | 23.48% |
| 2018 Q4 | 991.23 Million INR | 6.13% |
| 2018 Q3 | 934 Million INR | -20.38% |
| 2018 Q2 | 1.17 Billion INR | 14.22% |
| 2018 Q1 | 1.02 Billion INR | 19.0% |
| 2018 FY | 2.55 Billion INR | -29.48% |
| 2017 Q2 | 1.03 Billion INR | 17.95% |
| 2017 Q4 | 863 Million INR | 7.34% |
| 2017 FY | 3.62 Billion INR | 73.15% |
| 2017 Q3 | 804 Million INR | -22.54% |
| 2017 Q1 | 880 Million INR | 31.66% |
| 2016 Q4 | 668.4 Million INR | 11.27% |
| 2016 FY | 2.09 Billion INR | 14.9% |
| 2016 Q3 | 600.7 Million INR | -38.7% |
| 2016 Q2 | 980 Million INR | 29.73% |
| 2016 Q1 | 755.4 Million INR | 13.37% |
| 2015 Q4 | 666.3 Million INR | -17.08% |
| 2015 FY | 1.82 Billion INR | 41.54% |
| 2015 Q1 | 598.6 Million INR | 1303.46% |
| 2015 Q2 | 490.2 Million INR | -18.11% |
| 2015 Q3 | 803.5 Million INR | 63.91% |
| 2014 Q3 | 439.8 Million INR | 0.0% |
| 2014 FY | 1.28 Billion INR | 13.22% |
| 2014 Q4 | -49.74 Million INR | -111.31% |
| 2013 FY | 1.13 Billion INR | 45.02% |
| 2012 FY | 784.39 Million INR | 15.46% |
| 2011 FY | 679.39 Million INR | 53.65% |
| 2010 FY | 442.17 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 711.88 Million INR | -1115.795% |
| Metropolis Healthcare Limited | 2.05 Billion INR | -321.092% |
| Thyrocare Technologies Limited | 917 Million INR | -843.839% |
| Vijaya Diagnostic Centre Limited | 3.62 Billion INR | -138.526% |
| Vimta Labs Limited | 1.22 Billion INR | -605.189% |